About Wakamoto Pharmaceutical
Wakamoto Pharmaceutical is a publicly listed company based in Tokyo (Japan) founded in 1929. Ketone-based dietary supplements are manufactured and sold. Its website wakamoto-pharm.co.jp draws about 203 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Wakamoto Pharmaceutical was established in 1929 in Tokyo, Japan. Ketone-based dietary supplements are developed and marketed within the health and nutrition sector. These products are formulated to aid ketosis maintenance, cognitive performance, and energy provision for ketogenic diet adherents. Related items supporting ketogenic routines are also produced, with scientific studies informing product standards. Operations remain centered in Japan, serving domestic and potential international markets.
- Headquarters Tokyo, Japan
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website wakamoto-pharm.co.jp
- Legal Name Wakamoto Pharmaceutical Co., Ltd.
- Annual Revenue$62.13 M (USD)27.18as on Mar 31, 2026
- Net Profit$1.42 M (USD)252.6as on Mar 31, 2026
- EBITDA$3.93 M (USD)as on Mar 31, 2026
People of Wakamoto Pharmaceutical
11 people are tracked at Wakamoto Pharmaceutical (1 in leadership, 5 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Arata Igarashi | President & Representative Director | Leadership |
Akihiko Tanigaki | Director | Board & advisors |
Hiroyoshi Kasai | Director | Board & advisors |
Haruhisa Hirata | Director | Board & advisors |
Kimihiko Sato | Director | Board & advisors |
Katsuyoshi Ejima | Outside Director | Board & advisors |
Makoto Taniguchi | Executive Officer | Team |
Hiroki Sanada | Executive Officer | Team |
Mizuho Koike | Executive Officer | Team |
Noboru Yamazaki | Senior Executive Officer | Team |
Akimi Yoshida | Executive Officer | Team |
Complete people profiles for Wakamoto Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Wakamoto Pharmaceutical
Wakamoto Pharmaceutical is a publicly listed company on the TSE with ticker symbol 4512 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 May 1949
- Listed onTSE: 4512
- Listed entityWakamoto Pharmaceutical Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3991200001
- Share price301.00 JPY (+0.33% on the day) · 2026-10-14
- Market capitalisation10,412,203,217.00 JPY
- Price to earnings30.5
- EPS (diluted, trailing year)9.87 JPY
- Dividend yield1.16%
- Volume (last session)20,900
Financials of Wakamoto Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 9.91B JPY | 227.2M JPY | 626.2M JPY |
| 2024 | 7.79B JPY | 64.4M JPY | -94.6M JPY |
| 2023 | 7.74B JPY | 109.0M JPY | 149.9M JPY |
| 2022 | 8.66B JPY | 138.3M JPY | 505.1M JPY |
| 2021 | 8.38B JPY | 238.5M JPY | 456.7M JPY |
Detailed financial statements for Wakamoto Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Wakamoto Pharmaceutical
The website of Wakamoto Pharmaceutical (wakamoto-pharm.co.jp) receives about 203.2K visits a month and ranks #227,483 among all websites worldwide, #7,527 in Biotechnology and Pharmaceuticals.
- Monthly visits203.2K
▼ 20.6% vs previous month
- Unique visitors153.2K
per month
- Global rank#227,483
among all websites
- Category rank#7,527
Health · Biotechnology and Pharmaceuticals
- Bounce rate50%
- Pages per visit1.3
- Average visit38 sec
- DevicesDesktop 12% · Mobile 88%
Websites whose visitors overlap most with Wakamoto Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
maruishi-pharm.co.jp | maruishi-pharm.co.jp | 100% | #719,228 | – | |
investor.ironwoodpharma.com | investor.ironwoodpharma.com | 98% | – | ||
| seirogan.co.jp | 97% | 198.7K | #220,107 | View details | |
| nbpharma.com | 97% | 1.6K | #7,824,941 | View details | |
| taiho.co.jp | 93% | #293,478 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Wakamoto Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Wakamoto Pharmaceutical
Complete news archive for Wakamoto Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wakamoto Pharmaceutical
Wakamoto Pharmaceutical was founded in 1929.
Wakamoto Pharmaceutical is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Annual revenue of Wakamoto Pharmaceutical is $62.13M as on Mar 31, 2026.
Wakamoto Pharmaceutical was established in 1929 in Tokyo, Japan. Ketone-based dietary supplements are developed and marketed within the health and nutrition sector. These products are formulated to aid ketosis maintenance, cognitive performance, and energy provision for ketogenic diet adherents. Related items supporting ketogenic routines are also produced, with scientific studies informing product standards. Operations remain centered in Japan, serving domestic and potential international markets.
Yes, Wakamoto Pharmaceutical is publicly traded on TSE under the ticker symbol 4512.
The website of Wakamoto Pharmaceutical receives about 203 thousand visits a month and ranks #227,483 among all websites worldwide.